Silencing a liver gene may prevent brain damage from rare metabolic disease
What if the path to treating a rare condition that harms the brain goes through the liver? A new study by Duke University School of Medicine researchers is the first to show preclinical success of a liver-targeting treatment of glutaric aciduria type I (GA1).
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.